The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users
Open Access
- 1 October 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 32 (5) , 708-714
- https://doi.org/10.1093/ije/dyg102
Abstract
Prevalence of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in the injecting drug user (IDU) community can differ considerably. In Australia in 1997, HIV prevalence among attendees at Needle Exchange Programs was 1% while HCV prevalence was 50%. The impact that different needle-sharing behaviour and drug injecting use may have on the future levels of these viruses is uncertain.Keywords
This publication has 12 references indexed in Scilit:
- Estimating progression to cirrhosis in chronic hepatitis C virus infectionHepatology, 2001
- Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- Modelling the hepatitis C virus epidemic in AustraliaJournal of Gastroenterology and Hepatology, 1999
- Mathematical modelling of the spread of HIV/AIDS amongst injecting drug usersMathematical Medicine and Biology: A Journal of the IMA, 1997
- The HIV/AIDS epidemics among drug injectors: A study of contact structure through a mathematical modelMathematical Biosciences, 1997
- Transmission of Hepatitis C Virus: Rates, Routes, and CofactorsEpidemiologic Reviews, 1996
- Risk of hepatitis C seroconversion after occupational exposures in health care workers*1American Journal of Infection Control, 1995
- The basic reproduction ratio of HIV among intravenous drug usersMathematical Biosciences, 1994
- Drugs, sex and HIV : a mathematical model for New York CityPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1991
- Risk for Occupational Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) Associated with Clinical ExposuresAnnals of Internal Medicine, 1990